Navigation Links
Spin-out to apply new technology for tackling infection

A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

Fixed Phage Limited has been established to develop products based on its patented technology for treatment and prevention of infection and bacterial contamination in medicine, food safety, environmental sanitation and many other areas.

Initially the company will focus on wound care applications, and having already proven the technology's effectiveness in a prototype wound closure product, this will be extended to wound dressings able to combat those bacteria causing wound infections, such as MRSA.

The technology enables the powerful anti-bacterial properties of bacteriophages- naturally occurring viruses which are non-toxic to humans, animals and plants but which can destroy bacteria- to be incorporated into new and existing products.

Scottish venture capital company Barwell PLC is providing capital to support the new venture, in partnership with Scottish Enterprise's Scottish Co-Investment Fund, and is hopeful that the company will generate new jobs and opportunities. Working alongside industry, Fixed Phage plans to create, test and produce a wide range of antimicrobial products.

The initial development of the technology was funded through the former Synergy Fund, owned by Strathclyde and the University of Glasgow, and through Scottish Enterprise's Proof of Concept Programme.

Dr Mike Mattey, Honorary Lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences and Chief Scientific Officer of Fixed Phage, said: "Bacterial infection is a huge challenge for hospitals and healthcare; and can be at least as harmful to patients as the illnesses they are being treated for.

"We have had highly promising trial results with a prototype and are looking forward to delivering treatment to the patients who need it and cost-effective solutions for the health professionals who look after them. We have been able to stabilise bacteriophage and develop the technology for application in combating these infections."

Dr Jim Chadwick, Chief Executive of Fixed Phage, said: "The terrific potential of bacteriophage as an agent to combat infection has been known for some years but it has proved difficult to incorporate into products that are easily manufactured and offer patent protection. This superb technology, invented in Scotland, allows both these objectives to be achieved simultaneously and a prototype has been demonstrated in rigorous trial.

"FixedPhage technology can be applied to prevent infection from appearing or deal with established infection, and unlike antibiotics, has the advantage that bacteriophage constantly overcome bacterial resistance and once established, the bacterial destruction process becomes self-amplifying."

"We have shown the technology to be effective in combating infection and the model gives us options for many other applications. We anticipate significant commercial interest, particularly from the pharmaceutical industry."

Strathclyde Institute of Pharmacy and Biomedical Sciences, where the technology was discovered, is a pioneering centre for developing new medicines for illnesses and conditions including infectious diseases, cancer, heart disease and arthritis. An 8 million fundraising campaign is underway for the Institute's new 36 million building, to expand and enhance its innovative medical research, education and discovery capability to continue providing solutions to major health care problems.

In November 2010, Fixed Phage Ltd was the winner of the Life Science Innovation Award at the 2010 Nexxus Annual Life Science Awards (West), run by the networking organisation for Scotland's life scientists.

Initially, the new company will be based at, and contactable at, the University of Strathclyde.

The spin-out agreement was negotiated for Strathclyde by Dr Catherine Breslin, Research & Knowledge Exchange Manager, and Louise McKean, Contracts Manager, of the University's Research & Knowledge Exchange Services.


Contact: Paul Gallagher
University of Strathclyde

Related biology news :

1. Researchers apply systems biology and glycomics to study human inflammatory diseases
2. Experts discuss applying systematic review to the field of nutrition
3. Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests
4. Carnegie Mellon researchers apply new statistical test
5. Researchers apply computing power to crack egg shell problem
6. BIO-key(R) to Showcase Biometric Security Applications at 2008 Biometric Technology Expo
7. Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
8. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
9. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
10. Breakthrough optical technology to assess colon cancer risk, accuracy
11. So-called sandfish could help materials handling and process technology specialists
Post Your Comments:
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
(Date:11/17/2015)... November 17, 2015 Paris ... --> Paris from 17 th ... the biometrics innovation leader, has invented the first combined scanner ... the same scanning surface. Until now two different scanners were ... scanner can capture both on the same surface. This ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem ... and aesthetics professionals from Central America and abroad for the first Iberoamerican Convention ... Panama Feb. 17-19, 2016. Testart will present and discuss new trends in anti-aging ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global ... Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group GMP ... a world-class team of qualified medical researchers and practitioners, experienced in administering stem ...
(Date:11/30/2015)... interventional radiology technique shows promise for helping morbidly obese patients ... being presented today at the annual meeting of the Radiological ... --> --> Gastric artery ... a way to stop bleeding in emergency situations, but the ... obesity is new. Mubin Syed , M.D., interventional ...
(Date:11/30/2015)... , December 1, 2015 Partnership includes an ... for the u niversity , ... support treatment s cale - up ... (ARVs)   Africa , where licensees based anywhere in the ... on SDN technology. --> Africa , where licensees based anywhere ...
Breaking Biology Technology: